The recruitment of this myeloid population was through increased CXCL17 secretion by p53-null prostate cancer cells, and their role in promoting tumor development was associated with the expansion of immunosuppressive Treg cells (Bezzi et al., 2018). This evidence concerns the gene TP53 and prostate cancer.